Cargando…

Cannabinoids in the management of difficult to treat pain

This article reviews recent research on cannabinoid analgesia via the endocannabinoid system and non-receptor mechanisms, as well as randomized clinical trials employing cannabinoids in pain treatment. Tetrahydrocannabinol (THC, Marinol(®)) and nabilone (Cesamet(®)) are currently approved in the Uni...

Descripción completa

Detalles Bibliográficos
Autor principal:	Russo, Ethan B
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/ https://www.ncbi.nlm.nih.gov/pubmed/18728714

Ejemplares similares

Management of difficult-to-treat asthma in adolescence and young adults
por: Mansur, Adel H., et al.
Publicado: (2023)

Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
por: Stella, Barbara, et al.
Publicado: (2021)

Managing chronic hepatitis C in the difficult-to-treat patient
por: Kemmer, Nyingi, et al.
Publicado: (2007)

Cannabinoid therapeutics in orofacial pain management: a systematic review
por: Votrubec, C, et al.
Publicado: (2022)

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
por: Armuzzi, Alessandro, et al.
Publicado: (2013)

Novel drugs in the management of difficult-to-treat hepatitis C genotypes
por: Cartwright, Emily J, et al.
Publicado: (2013)

Targeting the endogenous cannabinoid system to treat neuropathic pain
por: Lau, Benjamin K., et al.
Publicado: (2014)

Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma
por: Casanova, M, et al.
Publicado: (2011)

Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain
por: Ryz, Natasha R., et al.
Publicado: (2017)

Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation
por: Russo, Ethan B., et al.
Publicado: (2022)

Abatacept in difficult-to-treat juvenile idiopathic arthritis
por: Kuemmerle-Deschner, Jasmin B, et al.
Publicado: (2008)

Adenomyosis: Difficult to Diagnose, and Difficult to Treat
por: Wood, C.
Publicado: (2001)

Difficult-to-treat asthma, is it really difficult?
por: Al-Hajjaj, Mohamed S.
Publicado: (2011)

The Role of Cannabinoid Receptors in the Descending Modulation of Pain
por: Palazzo, Enza, et al.
Publicado: (2010)

Cannabinoid Delivery Systems for Pain and Inflammation Treatment
por: Bruni, Natascia, et al.
Publicado: (2018)

A model for the management of difficult to treat depression
por: Mcallister-Williams, H.
Publicado: (2021)

Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness
por: Nicolescu, Alin Codrut, et al.
Publicado: (2022)

Difficult-to-Treat Pathogens: A Review on the Management of Multidrug-Resistant Staphylococcus epidermidis
por: Siciliano, Valentina, et al.
Publicado: (2023)

Cannabinoids in the treatment of pain
por: Kara, Eleana, et al.
Publicado: (2010)

Difficult medical management
por: Bell, P M
Publicado: (1991)

Pharmacogenetics: A hope for difficult to treat chronic pain patients
por: Mahajan, Rajiv
Publicado: (2016)

Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases
por: Holloman, Bryan Latrell, et al.
Publicado: (2021)

Difficult-To-Treat Depression. Scoping Review
por: Paganin, Walter, et al.
Publicado: (2023)

Recent data on cannabinoids and their pharmacological implications in neuropathic pain
por: Oana, Andreia Coman, et al.
Publicado: (2008)

Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain
por: Casey, Sherelle L., et al.
Publicado: (2018)

Microglial Cannabinoid CB(2) Receptors in Pain Modulation
por: Xu, Kangtai, et al.
Publicado: (2023)

Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks
por: Ang, Samuel P., et al.
Publicado: (2023)

Cannabinoids as an Alternative Option for Conventional Analgesics in Cancer Pain Management: A Pharmacogenomics Perspective
por: Jose, Anmi, et al.
Publicado: (2020)

Novel Solventless Extraction Technique to Preserve Cannabinoid and Terpenoid Profiles of Fresh Cannabis Inflorescence
por: Russo, Ethan B., et al.
Publicado: (2021)

Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
por: Hossain, Mohammad Zakir, et al.
Publicado: (2020)

The Endocannabinoid System, Cannabinoids, and Pain
por: Fine, Perry G., et al.
Publicado: (2013)

Clinical review: Management of difficult airways
por: Langeron, Olivier, et al.
Publicado: (2006)

Management of comorbidities in difficult and severe asthma
por: Khan, Jehangir, et al.
Publicado: (2023)

Cannabinoids in the management of spasticity associated with multiple sclerosis
por: Malfitano, Anna Maria, et al.
Publicado: (2008)

NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System
por: Vanegas, Horacio, et al.
Publicado: (2010)

Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
por: Tamba, Bogdan Ionel, et al.
Publicado: (2020)

Human fusariosis: An emerging infection that is difficult to treat
por: Batista, Bruna Gerardon, et al.
Publicado: (2020)

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2022)

Difficult-to-treat-pediatric Crohn’s disease: focus on adalimumab
por: Zeisler, Bella, et al.
Publicado: (2015)

Role of Antifungal Combinations in Difficult to Treat Candida Infections
por: Vitale, Roxana G.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i1ec7pnqpb54rpvd4g5jr3n4pf